Revelation Biosciences Inc (REVB)
2.20
-0.03
(-1.35%)
USD |
NASDAQ |
May 09, 16:00
2.19
-0.01
(-0.45%)
After-Hours: 20:00
Revelation Biosciences Shares Outstanding: 1.633M for March 18, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
March 18, 2024 | 1.633M |
February 05, 2024 | 0.3964M |
February 01, 2024 | 0.2679M |
January 30, 2024 | 0.2099M |
January 25, 2024 | 0.2099M |
January 22, 2024 | 0.2099M |
December 31, 2023 | 0.2645M |
December 20, 2023 | 0.2099M |
December 19, 2023 | 0.2093M |
November 06, 2023 | 0.2099M |
September 30, 2023 | 0.2099M |
August 07, 2023 | 0.2099M |
June 30, 2023 | 0.2099M |
May 25, 2023 | 0.2016M |
May 16, 2023 | 0.2016M |
May 05, 2023 | 0.1925M |
April 24, 2023 | 0.1864M |
March 31, 2023 | 0.1577M |
March 21, 2023 | 0.1504M |
February 13, 2023 | 0.119M |
Date | Value |
---|---|
February 12, 2023 | 0.0228M |
February 09, 2023 | 0.0224M |
January 09, 2023 | 0.0224M |
December 31, 2022 | 0.0228M |
December 20, 2022 | 0.0224M |
November 07, 2022 | 0.0224M |
October 06, 2022 | 0.0224M |
September 30, 2022 | 0.0224M |
August 11, 2022 | 0.0223M |
July 28, 2022 | 0.0223M |
July 25, 2022 | 0.0144M |
June 30, 2022 | 0.0144M |
June 10, 2022 | 0.0144M |
May 26, 2022 | 0.0144M |
May 13, 2022 | 0.0144M |
April 13, 2022 | 0.0144M |
March 31, 2022 | 0.0144M |
February 07, 2022 | 0.0136M |
January 25, 2022 | 0.0136M |
January 11, 2022 | 0.0123M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
0.0123M
Minimum
Jan 11 2022
1.633M
Maximum
Mar 18 2024
0.1506M
Average
0.0709M
Median
Shares Outstanding Benchmarks
Cardiff Oncology Inc | 44.72M |
Ocular Therapeutix Inc | 148.63M |
Ocugen Inc | 257.33M |
Cue Biopharma Inc | 48.64M |
Solid Biosciences Inc | 37.86M |